Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision v3.3.4 was added and Revision v3.3.3 was removed; this is a routine page update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:42:34.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The study's location information was reorganized: a consolidated 'Locations' section was added, and the per-state subsections for California, Louisiana, New York, Ohio, and Texas were removed (revision v3.3.3).
    Difference
    0.7%
    Check dated 2025-12-23T17:32:28.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:22:08.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Deleted the funding/operating-status notice banner at the top of the study record page; the remaining study content is unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T18:40:23.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    No significant changes to core content were detected; the updates appear to be minor editorial or formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:17:40.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T04:14:49.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.